Table 2

Major Adverse Events at 30 Days and at 12 Months

EVEREST High-Risk Cohort
(N = 351)
30 Days12 Months
Death4.8 (17/351)22.8 (80/351)
Myocardial infarction1.1 (4/351)2.3 (8/351)
Reoperation for failed surgical repair or replacement0.0 (0/351)0.0 (0/351)
Nonelective cardiovascular surgery for adverse events0.3 (1/351)0.3 (1/351)
Stroke2.6 (9/351)3.4 (12/351)
Renal failure1.7 (6/351)5.4 (19/351)
Deep wound infection0.0 (0/351)0.0 (0/351)
Ventilation >48 h2.8 (10/351)5.4 (19/351)
Gastrointestinal complication requiring surgery0.3 (1/351)1.4 (5/351)
New onset of permanent atrial fibrillation0.3 (1/351)0.3 (1/351)
Septicemia0.9 (3/351)4.3 (15/351)
Blood transfusion ≥2 U13.4 (47/351)22.5 (79/351)
Total18.8 (66/351)37.6 (132/351)
Total (excluding blood transfusions ≥2 U)9.1 (32/351)27.9 (98/351)

Values are % (n/N).

  • Total number of patients may not equal the sum of patients in each row because 1 patient may experience multiple events.